Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Clean Science
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel

Clean Science

WEBSITE BSE:543318 NSE: CLEAN Inc. Year: 2003 Industry: Chemicals My Bucket: Add Stock

₹757.4 5.8 | 0.8%

Last updated: 15:59

Consolidated Standalone

Last updated: 15:59

Clean Science Overview

Clean Science and Technology Limited engages within the research, improvement, manufacture, and marketing of speciality chemical compounds in India and the world over. The organisation offers guaiacol, 4-methoxy acetophenone, butylated hydroxy anisole, anisole, mono methyl ether of hydroquinone, L-ascorbyl palmitate, and N,N'-dicyclohexylcarbodiimide. It serves purchaser and business markets. The organization incorporated in 2003 and is primarily based in Pune, India.

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Clean Science Key Financials

Market Cap ₹8049 Cr.

Stock P/E 30.4

P/B 5.2

Current Price ₹757.4

Book Value ₹ 145.5

Face Value 1

52W High ₹1599

Dividend Yield 0.79%

52W Low ₹ 652.8

Edit Ratio

Clean Science Share Price

₹ | |

Volume
Price

Clean Science Quarterly Price

Quarterly Monthly
Show Value Show %

Clean Science Peer Comparison

Clean Science Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 181 195 228 224 238 241 264 243 245 220
Other Income 6 8 14 10 11 5 12 13 7 10
Total Income 187 203 242 234 249 246 276 256 251 229
Total Expenditure 106 108 133 129 148 142 159 143 158 147
Operating Profit 81 94 109 105 101 104 117 113 94 82
Interest 0 0 1 0 0 0 0 0 0 0
Depreciation 11 11 13 16 18 18 17 19 19 19
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 69 83 95 89 83 85 100 95 75 63
Provision for Tax 17 20 25 23 24 20 25 24 19 17
Profit After Tax 52 63 70 66 59 66 74 70 55 46
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 52 63 70 66 59 66 74 70 55 46
Adjusted Earnings Per Share 4.9 5.9 6.6 6.2 5.5 6.2 7 6.6 5.2 4.3

Clean Science Profit & Loss

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Dec 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 241 393 419 0 512 685 936 791 967 972
Other Income 5 11 11 0 26 30 30 41 39 42
Total Income 246 405 430 0 538 715 966 833 1005 1012
Total Expenditure 167 257 234 0 253 385 533 459 579 607
Operating Profit 78 148 196 0 285 330 432 374 427 406
Interest 1 0 0 0 0 0 1 1 1 0
Depreciation 8 11 14 0 17 25 36 46 69 74
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 70 137 182 0 267 305 396 327 357 333
Provision for Tax 21 39 43 0 69 76 100 82 92 85
Profit After Tax 49 98 140 0 198 228 295 244 264 245
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 49 98 140 0 198 228 295 244 264 245
Adjusted Earnings Per Share 4.3 8.6 13.1 0 18.7 21.5 27.8 23 24.9 23.1

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 22% 12% 0% 0%
Operating Profit CAGR 14% 9% 0% 0%
PAT CAGR 8% 5% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -36% -19% NA% NA%
ROE Average 20% 25% 31% 34%
ROCE Average 27% 34% 42% 46%

Clean Science Balance Sheet

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Dec 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 188 272 342 0 540 768 1010 1203 1416
Minority's Interest 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 10 14 11 0 18 21 26 32 28
Total Current Liabilities 38 41 77 0 102 135 116 236 251
Total Liabilities 236 327 430 0 660 925 1152 1472 1695
Fixed Assets 102 127 166 0 186 296 460 636 715
Other Non-Current Assets 9 8 7 0 79 59 61 101 86
Total Current Assets 125 193 257 0 395 559 630 735 895
Total Assets 236 327 430 0 660 925 1152 1472 1695

Clean Science Cash Flow

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Dec 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 6 30 9 0 9 9 58 12 10
Cash Flow from Operating Activities 45 85 160 0 193 127 279 236 214
Cash Flow from Investing Activities -18 -95 -106 0 -187 -79 -270 -185 -152
Cash Flow from Financing Activities -5 -11 -55 0 -6 -0 -55 -53 -53
Net Cash Inflow / Outflow 22 -21 -2 0 0 49 -45 -2 10
Closing Cash & Cash Equivalent 30 9 9 0 9 58 12 10 20

Clean Science Ratios

# Mar 2018 Mar 2019 Mar 2020 Dec 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 4.32 8.62 13.14 0 18.68 21.51 27.78 22.97 24.88
CEPS(Rs) 4.99 9.59 14.43 0 20.3 23.86 31.18 27.29 31.38
DPS(Rs) 3 7.5 9 0 2.5 3.25 5 5 6
Book NAV/Share(Rs) 16.58 24.02 32.2 0 50.81 72.3 94.95 113.02 133.08
Core EBITDA Margin(%) 30.44 34.74 44.26 0 50.58 43.83 43.01 42 40.14
EBIT Margin(%) 29.18 34.8 43.58 0 52.23 44.57 42.34 41.41 36.99
Pre Tax Margin(%) 28.95 34.72 43.48 0 52.16 44.5 42.28 41.25 36.9
PAT Margin (%) 20.15 24.83 33.3 0 38.71 33.36 31.54 30.83 27.35
Cash Profit Margin (%) 23.28 27.64 36.57 0 42.07 37 35.4 36.63 34.5
ROA(%) 20.71 34.66 36.87 0 36.41 28.84 28.43 18.6 16.7
ROE(%) 26.03 42.47 45.47 0 45 34.95 33.23 22.09 20.22
ROCE(%) 37.58 59.11 59 0 60.5 46.65 44.55 29.62 27.3
Receivable days 59.65 46.14 56.41 0 51.31 60.69 58.46 71.46 69.31
Inventory Days 43.67 30.66 31.17 0 31.16 37.58 38.41 53.6 51.56
Payable days 84.98 51.96 81.94 0 142.77 132.49 102.25 122.63 106.46
PER(x) 0 0 0 0 0 92.65 45.51 57.83 46.91
Price/Book(x) 0 0 0 0 0 27.57 13.32 11.75 8.77
Dividend Yield(%) 0 0 0 0 0 0.16 0.4 0.38 0.51
EV/Net Sales(x) -0.11 -0.01 -0.01 0 -0.01 30.8 14.34 17.82 12.81
EV/Core EBITDA(x) -0.35 -0.04 -0.03 0 -0.02 63.9 31.04 37.73 29.03
Net Sales Growth(%) 0 63.13 6.62 0 22.21 33.66 36.64 -15.42 22.13
EBIT Growth(%) 0 93.28 33.51 0 46.46 14.05 29.8 -17.27 9.09
PAT Growth(%) 0 99.72 42.98 0 42.07 15.18 29.18 -17.33 8.35
EPS Growth(%) 0 99.72 52.45 0 42.1 15.18 29.16 -17.34 8.33
Debt/Equity(x) 0 0.01 0.01 0 0 0 0 0 0
Current Ratio(x) 3.31 4.68 3.34 0 3.87 4.15 5.46 3.11 3.56
Quick Ratio(x) 2.54 3.78 2.89 0 3.36 3.49 4.52 2.59 2.97
Interest Cover(x) 125.56 411.02 443.51 0 820.94 687.48 710.02 257.48 424.67
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0

Clean Science Shareholding Pattern

# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 74.98 74.98 74.98 74.97 74.97 74.97 74.97 50.97 50.96 51.29
FII 5.92 5.88 6.06 5.83 5.98 6.07 6.21 11.14 10 13.39
DII 5.14 5.04 4.55 4.77 5.46 5.76 5.92 18.98 19.77 17.16
Public 13.97 14.1 14.42 14.43 13.6 13.2 12.9 18.92 19.26 18.16
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Clean Science News

Clean Science Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 25%
  • Debtor days have improved from 122.63 to 106.46days.
  • Company is almost debt free.

Cons

  • Stock is trading at 5.2 times its book value.

* The pros and cons are machine generated.

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares
whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!